Necrotizing pneumonia and empyema due to Clostridium perfringens. Report of a case and review of the literature.
Bayer AS, Nelson SC, Galpin JE, Chow AW, Guze LB.
Am J Med. 1975 Dec;59(6):851-6. doi: 10.1016/0002-9343(75)90471-4.
BACTERIAL NUCLEOTIDASES.
KOHN J, REIS JL.
J Bacteriol. 1963 Oct;86(4):713-6. doi: 10.1128/jb.86.4.713-716.1963.
Clostridium perfringens empyema after right hemicolectomy for caecal volvulus.
Morocho B, Nikoleta T, Morocho C, McElhaney N.
BMJ Case Rep. 2023 Dec 21;16(12):e256551. doi: 10.1136/bcr-2023-256551.
Linezolid.
Clemett D, Markham A.
Drugs. 2000 Apr;59(4):815-27; discussion 828. doi: 10.2165/00003495-200059040-00007.
Clostridium perfringens enterotoxin in antibiotic-associated diarrhea.
Vaishnavi C, Kaur S.
Indian J Pathol Microbiol. 2008 Apr-Jun;51(2):198-9. doi: 10.4103/0377-4929.41681.
Necrotizing pneumonia and sepsis due to Clostridium perfringens: a case report.
Palmacci C, Antocicco M, Bonomo L, Maggi F, Cocchi A, Onder G.
Cases J. 2009 Jan 14;2(1):50. doi: 10.1186/1757-1626-2-50.
Bacterial Infections and Cancer: Exploring This Association And Its Implications for Cancer Patients.
Yusuf K, Sampath V, Umar S.
Int J Mol Sci. 2023 Feb 4;24(4):3110. doi: 10.3390/ijms24043110.
CPET for Long COVID-19.
Naeije R, Caravita S.
JACC Heart Fail. 2022 Mar;10(3):214-215. doi: 10.1016/j.jchf.2022.01.008.
Acute emphysematous cholecystitis due to clostridium perfringens: a rare entity requiring aggressive and early treatment.
Santoyo Villalba J, Cañas García I, Mogollón González M.
Rev Esp Enferm Dig. 2022 Jun;114(6):357-358. doi: 10.17235/reed.2022.8631/2022.
Ertapenem: a new carbapenem.
Odenholt I.
Expert Opin Investig Drugs. 2001 Jun;10(6):1157-66. doi: 10.1517/13543784.10.6.1157.
